DRUG
Bright Minds Biosciences Inc
NASDAQ: DRUG · HEALTHCARE · BIOTECHNOLOGY
$89.11
+0.13% today
Updated 2026-04-29
Market cap
$872.62M
P/E ratio
—
P/S ratio
—
EPS (TTM)
$-2.02
Dividend yield
—
52W range
$23 – $124
Volume
0.2M
Bright Minds Biosciences Inc (DRUG) Financial statements
SEC filings — annual and quarterly data.
Income statement — annual
| Item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| Revenue | — | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Revenue growth (YoY) | — | — | — | — | — | — | — |
| Cost of revenue | — | — | — | $6037.00 | $72450.00 | — | $55191.00 |
| Gross profit | — | — | — | $-6037.00 | $-72450.00 | — | $-76976.00 |
| Gross margin | — | — | — | — | — | — | — |
| R&D | $126027.00 | $354852.00 | $6.31M | $12.18M | $5.00M | $1.18M | $11.08M |
| SG&A | $110124.00 | $104888.00 | $1.44M | $2.00M | $2.08M | $1.40M | $2.14M |
| Operating income | $-236151.00 | $-469358.00 | $-8.76M | $-14.98M | $-7.39M | $-2.82M | $-13.94M |
| Operating margin | — | — | — | — | — | — | — |
| EBITDA | $-78720.00 | $-469358.00 | $-8.76M | $-14.97M | $-7.31M | $-2.75M | $-13.86M |
| EBITDA margin | — | — | — | — | — | — | — |
| EBIT | $-314871.00 | $-469358.00 | $-8.76M | $-14.98M | $-7.39M | $-2.82M | $-13.94M |
| Interest expense | $0.00 | $0.00 | $0.00 | $222777.00 | $19750.00 | — | $25741.00 |
| Income tax | — | — | — | — | — | — | — |
| Effective tax rate | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
| Net income | $-236151.00 | $-485945.00 | $-8.52M | $-14.96M | $-7.37M | $-2.80M | $-12.23M |
| Net income growth (YoY) | — | -105.8% | -1652.3% | -75.7% | +50.7% | +62.0% | -336.5% |
| Profit margin | — | — | — | — | — | — | — |